Cyril Amarchand Mangaldas advised Ayu Health and Vertex Ventures
Leading Law Firm Cyril Amarchand Mangaldas advised Plus Health Tech Ventures (Ayu Health) and Vertex Ventures (an existing
Cyril Amarchand Mangaldas advised Ayu Health and Vertex Ventures
Leading Law Firm Cyril Amarchand Mangaldas advised Plus Health Tech Ventures (Ayu Health) and Vertex Ventures (an existing investor in Ayu Health), in relation to the Series B round of funding of Ayu Health.
The General Corporate Practice of Cyril Amarchand Mangaldas advised Ayu Health, and Vertex Ventures Sea Fund - IV Pte Limited on the Transaction. The Transaction was led by Nagavalli G, Partner; with support from Ayushi Mishra, Senior Associate.
As a part of the Series B funding transaction, Ayu Health issued and allotted Compulsorily Convertible Preference Shares (CCPS) and equity shares, by way of preferential allotment on a private placement basis, for an aggregate investment amount of INR 161,69,65,644 crore. Simultaneously, the existing shareholders of Ayu Health transferred certain equity shares for an aggregate purchase consideration of INR 3,03,90,840 crore.
The total aggregate investment amount was for INR 164 crore (appox.).
The Transaction was signed on 12th April, 2022 and was closed on 30th April, 2022.